Kingworld Medicines Group (HKSE:01110) 3-Year Book Growth Rate : -1.20% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group 3-Year Book Growth Rate?

Kingworld Medicines Group's Book Value per Share for the quarter that ended in Dec. 2023 was HK$1.09.

During the past 12 months, Kingworld Medicines Group's average Book Value per Share Growth Rate was -1.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was -1.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was 1.20% per year. During the past 10 years, the average Book Value per Share Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Kingworld Medicines Group was 29.00% per year. The lowest was -3.30% per year. And the median was 3.45% per year.

Competitive Comparison of Kingworld Medicines Group's 3-Year Book Growth Rate

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kingworld Medicines Group's 3-Year Book Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's 3-Year Book Growth Rate falls into.

Kingworld Medicines Group 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Kingworld Medicines Group (HKSE:01110) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Kingworld Medicines Group 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kingworld Medicines Group (HKSE:01110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016

Website

https://www.kingworld.com.cn

Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines